BaseSpace
Correlation
Engine-Public
Sign In
Register
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Hypothalamus
,
Hematopoietic cell
,
Tamoxifen
,
rs2230926
,
ZBTB7A
,
HIV infection
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
malignant ascites
(phenotype)
Summary
General Info
Genetic Markers
Most Correlated Genes
Most Correlated SNPs
No genes found
No SNPs found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
GSK cancer cell line transcript profiling
Breast, endometrial and ovarian cancer cell lines treated with eribulin or paclitaxel
Cancer cell lines treated with BET inhibitor GSK525762 and/or MEK inhibitor trametinib
Pancreatic carcinoma YAPC cells with dox-induced expression of GLI2
Ovarian cancer SKOV3-ip1 cells; metastasis to omentum
Explore Curated Studies Results
Literature
Most Relevant Literature
Malignant ascites: pathophysiology and treatment.
The FACIT-AI, a new tool for assessing symptoms associated with malignant ascites.
The contribution of catumaxomab in the treatment of malignant ascites in patients with ovarian cance…
Intractable malignant ascites: an alternative management option.
Malignant ascites: A review of prognostic factors, pathophysiology and therapeutic measures.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
EUS-Guided Drainage of Refractory Malignant Ascites
Malignant Ascites AlfapumpĀ® Study
Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites
Retrospective Study in the Use of the Alfapump and the Treatment of Malignant Ascites
Treat Malignant Ascites Caused by Gastrointestinal or Ovarian Cancer With M701 Bispecific Antibody
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ